159 related articles for article (PubMed ID: 16083917)
1. Development of cancer chemopreventive drugs based on mechanistic approaches.
Steele VE; Kelloff GJ
Mutat Res; 2005 Dec; 591(1-2):16-23. PubMed ID: 16083917
[TBL] [Abstract][Full Text] [Related]
2. Current mechanistic approaches to the chemoprevention of cancer.
Steele VE
J Biochem Mol Biol; 2003 Jan; 36(1):78-81. PubMed ID: 12542978
[TBL] [Abstract][Full Text] [Related]
3. Surrogate end-point biomarkers in chemopreventive drug development.
Kelloff GJ; Sigman CC; Hawk ET; Johnson KM; Crowell JA; Guyton KZ
IARC Sci Publ; 2001; 154():13-26. PubMed ID: 11220652
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic considerations in the evaluation of chemopreventive data.
Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet RA; Greenwald P; Hawk ET; Fay JR; Sigman CC
IARC Sci Publ; 1996; (139):203-19. PubMed ID: 8923032
[TBL] [Abstract][Full Text] [Related]
5. Prevention of prostate cancer through custom tailoring of chemopreventive regimen.
Siddiqui IA; Afaq F; Adhami VM; Mukhtar H
Chem Biol Interact; 2008 Jan; 171(2):122-32. PubMed ID: 17403520
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
7. Targeting signal transduction pathways by chemopreventive agents.
Bode AM; Dong Z
Mutat Res; 2004 Nov; 555(1-2):33-51. PubMed ID: 15476850
[TBL] [Abstract][Full Text] [Related]
8. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
9. Cancer chemopreventive agents-drugs for the 21st century?
Baer-Dubowska W
Acta Pol Pharm; 2006; 63(5):369-73. PubMed ID: 17357586
[TBL] [Abstract][Full Text] [Related]
10. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways.
Ramos S
Mol Nutr Food Res; 2008 May; 52(5):507-26. PubMed ID: 18435439
[TBL] [Abstract][Full Text] [Related]
11. Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents.
Boone CW; Bacus JW; Bacus JV; Steele VE; Kelloff GJ
J Cell Biochem Suppl; 1997; 28-29():1-20. PubMed ID: 9589346
[TBL] [Abstract][Full Text] [Related]
12. Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need.
Herberman RB; Pearce HL; Lippman SM; Pyenson BS; Alberts DS
Cancer Res; 2006 Dec; 66(24):11540-9. PubMed ID: 17158189
[TBL] [Abstract][Full Text] [Related]
13. Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin.
Raju J; Mehta R
Nutr Cancer; 2009; 61(1):27-35. PubMed ID: 19116873
[TBL] [Abstract][Full Text] [Related]
14. The convergent development of molecular-targeted drugs for cancer treatment and prevention.
Lippman SM; Heymach JV
Clin Cancer Res; 2007 Jul; 13(14):4035-41. PubMed ID: 17634526
[TBL] [Abstract][Full Text] [Related]
15. The new biology of cancer: future clinical applications.
Yarbro JW
Semin Oncol; 1989 Jun; 16(3):254-9. PubMed ID: 2658085
[TBL] [Abstract][Full Text] [Related]
16. The role of human adult stem cells and cell-cell communication in cancer chemoprevention and chemotherapy strategies.
Trosko JE; Chang CC; Upham BL; Tai MH
Mutat Res; 2005 Dec; 591(1-2):187-97. PubMed ID: 16084532
[TBL] [Abstract][Full Text] [Related]
17. [Generalities about carcinogenesis].
Tubiana M
C R Biol; 2008 Feb; 331(2):114-25. PubMed ID: 18241804
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention: from research to clinical oncology.
Veronesi U; Bonanni B
Eur J Cancer; 2005 Sep; 41(13):1833-41. PubMed ID: 16061373
[TBL] [Abstract][Full Text] [Related]
19. Cancer chemoprevention: a summary of the current evidence.
Bonovas S; Tsantes A; Drosos T; Sitaras NM
Anticancer Res; 2008; 28(3B):1857-66. PubMed ID: 18630472
[TBL] [Abstract][Full Text] [Related]
20. Are critical normal gene products in cancer cells the real therapeutic targets?
Warenius HM
Anticancer Res; 2002; 22(5):2651-5. PubMed ID: 12529977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
